MFS
AGRX

MSI Financial Services’s Agile Therapeutics AGRX Stock Holding History

MSI Financial Services’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Hold
0
– -$3K – 4140
2016
Q1 		– Sell
-1
Closed -$12.9K – 3445
2015
Q4 		$10K Hold
1
– – ﹤0.01% 2721
2015
Q3 		$7K Hold
1
– – ﹤0.01% 2268
2015
Q2 		$9K Buy
+1
New +$21.3K ﹤0.01% 2210

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

MSI Financial Services's AGRX Position: Q2 2016 in Review

MSI Financial Services held its Agile Therapeutics (AGRX) position steady in Q2 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4140.

MSI Financial Services first reported a position in AGRX in Q2 2015 and has held it in 3 quarters since. The position peaked at $10K in Q4 2015. 50 funds tracked by Wall St. Rank hold AGRX as of Q2 2016.

  • MSI Financial Services held 0 shares of Agile Therapeutics worth $0 as of Q2 2016.
  • MSI Financial Services left its Agile Therapeutics share count unchanged in Q2 2016.
  • Agile Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q2 2016, its #4140 holding.
  • MSI Financial Services first reported a position in Agile Therapeutics in Q2 2015 and has held it in 3 quarters since.
  • MSI Financial Services's Agile Therapeutics position peaked at $10K in Q4 2015.
  • 50 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2016.

Based on MSI Financial Services's 13F filing for Q2 2016, filed 25 Jul 2016.